Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-05

AUTHORS

Marc C. Chamberlain

ABSTRACT

There is comparatively limited therapy for recurrent primary central nervous system lymphoma (PCNSL). Salvage therapies include re-challenge with high-dose methotrexate (HD-MTX), whole brain radiotherapy, temozolomide, topotecan and premetrexed. Bendamustine is a novel bifunctional alkylator with established activity in B cell systemic lymphomas but never previously evaluated in PCNSL. The objective of the current study was to assess response and toxicity of bendamustine in recurrent PCNSL following prior salvage therapy in a retrospective case series. Twelve adults [six males; six females: median age 59 years (range 43-74)] with HD-MTX refractory recurrent PCNSL were treated with bendamustine. All patients were treated at second recurrence following failure of prior salvage therapy. A cycle of bendamustine was defined as two consecutive days of treatment (100 mg/m(2)/day) administered once every 4 weeks (maximum number of cycles 6). Toxicities seen were Grade 2 (24 episodes in 10 patients) and 3 (10 episodes in 5 patients) only and included lymphopenia (8 patients), hyperglycemia (7 patients), fatigue (7 patients) and nausea (4 patients). The median number of cycles of therapy was 3.5 (range 1-6). Radiographic response was progressive disease in 5 (42%), stable disease in 1 (8%), partial response in 3 (25%) and complete response in 3 (25%). Median progression free survival (PFS) was 3.5 months (range 1-14 months) and 6-month PFS was 33 %. In this small retrospective series of select patients with recurrent PCNSL refractory to HD-MTX, bendamustine appears to have modest single agent activity with manageable toxicity. Confirmation in a larger series of similar patients is required. More... »

PAGES

155-162

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-014-1411-8

DOI

http://dx.doi.org/10.1007/s11060-014-1411-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1046834783

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24584709


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antimetabolites, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bendamustine Hydrochloride", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central Nervous System Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitrogen Mustard Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salvage Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, 825 Eastlake Ave E, MS: G4-940, 98109, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/11209510-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000180988", 
          "https://doi.org/10.2165/11209510-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000595164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.18.7252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000657227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/noq011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000678444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-013-1085-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002877031", 
          "https://doi.org/10.1007/s11060-013-1085-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003043958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603660", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003449325", 
          "https://doi.org/10.1038/sj.bjc.6603660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.13.524", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003658256"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1034/j.1600-0609.2003.00045.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004310095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-007-9464-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007719563", 
          "https://doi.org/10.1007/s11060-007-9464-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012698413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.11771", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013678538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.161", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017320169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-04-0159", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021593241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.20339", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026362836"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(09)61416-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031922698"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(10)70229-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034898942"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-013-1196-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035812481", 
          "https://doi.org/10.1007/s11060-013-1196-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.46.9957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041546845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl070", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041563711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11912-012-0251-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041742002", 
          "https://doi.org/10.1007/s11912-012-0251-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11912-012-0251-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041742002", 
          "https://doi.org/10.1007/s11912-012-0251-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045484144", 
          "https://doi.org/10.1038/sj.bmt.1705452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045484144", 
          "https://doi.org/10.1038/sj.bmt.1705452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.06.2117", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050156129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-011-0612-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050266838", 
          "https://doi.org/10.1007/s11060-011-0612-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-010-0497-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053593627", 
          "https://doi.org/10.1007/s11060-010-0497-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/80.17.1408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059814834"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.11.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.03.036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.8819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000137050.43114.42", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000137050.43114.42", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000137050.43114.42", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000276986.19602.c1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064349586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000276986.19602.c1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064349586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000276986.19602.c1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064349586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e31820f2d94", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e31820f2d94", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.0b013e31820f2d94", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064355987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.54.8.1707", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064378617"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.3.742", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074750681"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-05", 
    "datePublishedReg": "2014-05-01", 
    "description": "There is comparatively limited therapy for recurrent primary central nervous system lymphoma (PCNSL). Salvage therapies include re-challenge with high-dose methotrexate (HD-MTX), whole brain radiotherapy, temozolomide, topotecan and premetrexed. Bendamustine is a novel bifunctional alkylator with established activity in B cell systemic lymphomas but never previously evaluated in PCNSL. The objective of the current study was to assess response and toxicity of bendamustine in recurrent PCNSL following prior salvage therapy in a retrospective case series. Twelve adults [six males; six females: median age 59 years (range 43-74)] with HD-MTX refractory recurrent PCNSL were treated with bendamustine. All patients were treated at second recurrence following failure of prior salvage therapy. A cycle of bendamustine was defined as two consecutive days of treatment (100 mg/m(2)/day) administered once every 4 weeks (maximum number of cycles 6). Toxicities seen were Grade 2 (24 episodes in 10 patients) and 3 (10 episodes in 5 patients) only and included lymphopenia (8 patients), hyperglycemia (7 patients), fatigue (7 patients) and nausea (4 patients). The median number of cycles of therapy was 3.5 (range 1-6). Radiographic response was progressive disease in 5 (42%), stable disease in 1 (8%), partial response in 3 (25%) and complete response in 3 (25%). Median progression free survival (PFS) was 3.5 months (range 1-14 months) and 6-month PFS was 33 %. In this small retrospective series of select patients with recurrent PCNSL refractory to HD-MTX, bendamustine appears to have modest single agent activity with manageable toxicity. Confirmation in a larger series of similar patients is required.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-014-1411-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "118"
      }
    ], 
    "name": "Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series", 
    "pagination": "155-162", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "df1a59daf0b531b817e65b5169a7b1d6334c4d488614c6794052ced6143edc4b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24584709"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-014-1411-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1046834783"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-014-1411-8", 
      "https://app.dimensions.ai/details/publication/pub.1046834783"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T20:51", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000534.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-014-1411-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-014-1411-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-014-1411-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-014-1411-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-014-1411-8'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      82 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-014-1411-8 schema:about N20bf940dc2ea4bd281d1b8eca8e103f4
2 N21ba2644ba824b98a7132e4c7056650b
3 N26723dfa3d134709b92ade73a39274cc
4 N2f7ca54a9c7d4f179bd4a1109d632f60
5 N38f5d99867dd46c5a278466ff1f3906a
6 N3cca203c766a4466891149ef0a94e9cf
7 N479853f1c13944a0899ed4a25f17eed2
8 N50b1a1c105d740298d510c6039f4fefe
9 N532f4251a4d9498b88ff9e73313aecba
10 N5404fb0d6f50414fb6df6c9311a67f1b
11 N56a74da7d4654d26886d09ccee703cc3
12 N5d9435e70afd4af693f3cb2af58e3b2d
13 N8f1b8846d3ae482ba601583cd79f0fca
14 N9d812594681f442db7528c4527334bb8
15 Na0deb6ea4ebd492a9446d794947f1f0f
16 Nc878683238fa46e5bc3d5034bdfb391f
17 Ne23cf0278ace4c49a9abdeb0a5ba32d2
18 Ne800ee8bbdc94840b15f478e098fd71c
19 Nf7594704a6e948d594bc15fb719bb79d
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author N23841fc373f14d50aa1fa60e223e81a5
23 schema:citation sg:pub.10.1007/s11060-007-9464-6
24 sg:pub.10.1007/s11060-010-0497-x
25 sg:pub.10.1007/s11060-011-0612-7
26 sg:pub.10.1007/s11060-013-1085-7
27 sg:pub.10.1007/s11060-013-1196-1
28 sg:pub.10.1007/s11912-012-0251-y
29 sg:pub.10.1038/sj.bjc.6603660
30 sg:pub.10.1038/sj.bmt.1705452
31 sg:pub.10.2165/11209510-000000000-00000
32 https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y
33 https://doi.org/10.1002/cncr.20339
34 https://doi.org/10.1002/cncr.26709
35 https://doi.org/10.1016/s0140-6736(09)61416-1
36 https://doi.org/10.1016/s1470-2045(10)70229-1
37 https://doi.org/10.1034/j.1600-0609.2003.00045.x
38 https://doi.org/10.1093/annonc/mdl070
39 https://doi.org/10.1093/annonc/mdl458
40 https://doi.org/10.1093/jnci/80.17.1408
41 https://doi.org/10.1093/neuonc/noq011
42 https://doi.org/10.1158/1078-0432.ccr-04-0159
43 https://doi.org/10.1200/jco.2001.19.3.742
44 https://doi.org/10.1200/jco.2002.11.013
45 https://doi.org/10.1200/jco.2003.03.036
46 https://doi.org/10.1200/jco.2005.01.161
47 https://doi.org/10.1200/jco.2005.04.8819
48 https://doi.org/10.1200/jco.2005.13.524
49 https://doi.org/10.1200/jco.2006.06.2117
50 https://doi.org/10.1200/jco.2008.18.7252
51 https://doi.org/10.1200/jco.2012.46.9957
52 https://doi.org/10.1212/01.wnl.0000137050.43114.42
53 https://doi.org/10.1212/01.wnl.0000276986.19602.c1
54 https://doi.org/10.1212/wnl.0b013e31820f2d94
55 https://doi.org/10.1212/wnl.54.8.1707
56 https://doi.org/10.3324/haematol.11771
57 schema:datePublished 2014-05
58 schema:datePublishedReg 2014-05-01
59 schema:description There is comparatively limited therapy for recurrent primary central nervous system lymphoma (PCNSL). Salvage therapies include re-challenge with high-dose methotrexate (HD-MTX), whole brain radiotherapy, temozolomide, topotecan and premetrexed. Bendamustine is a novel bifunctional alkylator with established activity in B cell systemic lymphomas but never previously evaluated in PCNSL. The objective of the current study was to assess response and toxicity of bendamustine in recurrent PCNSL following prior salvage therapy in a retrospective case series. Twelve adults [six males; six females: median age 59 years (range 43-74)] with HD-MTX refractory recurrent PCNSL were treated with bendamustine. All patients were treated at second recurrence following failure of prior salvage therapy. A cycle of bendamustine was defined as two consecutive days of treatment (100 mg/m(2)/day) administered once every 4 weeks (maximum number of cycles 6). Toxicities seen were Grade 2 (24 episodes in 10 patients) and 3 (10 episodes in 5 patients) only and included lymphopenia (8 patients), hyperglycemia (7 patients), fatigue (7 patients) and nausea (4 patients). The median number of cycles of therapy was 3.5 (range 1-6). Radiographic response was progressive disease in 5 (42%), stable disease in 1 (8%), partial response in 3 (25%) and complete response in 3 (25%). Median progression free survival (PFS) was 3.5 months (range 1-14 months) and 6-month PFS was 33 %. In this small retrospective series of select patients with recurrent PCNSL refractory to HD-MTX, bendamustine appears to have modest single agent activity with manageable toxicity. Confirmation in a larger series of similar patients is required.
60 schema:genre research_article
61 schema:inLanguage en
62 schema:isAccessibleForFree false
63 schema:isPartOf N806608e5bf2a474bba2cacbb77b6d9b9
64 Nba9ce44920d543f09fbf1c5a3a64d224
65 sg:journal.1094205
66 schema:name Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series
67 schema:pagination 155-162
68 schema:productId N27e4efb799804d748ead3040ac8adee5
69 N45b87f9dbc1a407a8983b3a2fb5fbd4b
70 N7859aa86e33c4e7eb1781843fd943f68
71 N9af8070b0f7d40ac84065dde8e9400e1
72 Nef3e9b242ca640f3aeebaa7fe4413bc1
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046834783
74 https://doi.org/10.1007/s11060-014-1411-8
75 schema:sdDatePublished 2019-04-10T20:51
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher N25e1d60a186545838bed12e4f5c93dc8
78 schema:url http://link.springer.com/10.1007%2Fs11060-014-1411-8
79 sgo:license sg:explorer/license/
80 sgo:sdDataset articles
81 rdf:type schema:ScholarlyArticle
82 N20bf940dc2ea4bd281d1b8eca8e103f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Central Nervous System Neoplasms
84 rdf:type schema:DefinedTerm
85 N21ba2644ba824b98a7132e4c7056650b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Female
87 rdf:type schema:DefinedTerm
88 N23841fc373f14d50aa1fa60e223e81a5 rdf:first sg:person.01326261166.36
89 rdf:rest rdf:nil
90 N25e1d60a186545838bed12e4f5c93dc8 schema:name Springer Nature - SN SciGraph project
91 rdf:type schema:Organization
92 N26723dfa3d134709b92ade73a39274cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Middle Aged
94 rdf:type schema:DefinedTerm
95 N27e4efb799804d748ead3040ac8adee5 schema:name pubmed_id
96 schema:value 24584709
97 rdf:type schema:PropertyValue
98 N2f7ca54a9c7d4f179bd4a1109d632f60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Adult
100 rdf:type schema:DefinedTerm
101 N38f5d99867dd46c5a278466ff1f3906a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Antimetabolites, Antineoplastic
103 rdf:type schema:DefinedTerm
104 N3cca203c766a4466891149ef0a94e9cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Salvage Therapy
106 rdf:type schema:DefinedTerm
107 N4220b68a13734342a5ec63e587e46b9a schema:name Division of Neuro-Oncology, Department of Neurology and Neurological Surgery, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, 825 Eastlake Ave E, MS: G4-940, 98109, Seattle, WA, USA
108 rdf:type schema:Organization
109 N45b87f9dbc1a407a8983b3a2fb5fbd4b schema:name doi
110 schema:value 10.1007/s11060-014-1411-8
111 rdf:type schema:PropertyValue
112 N479853f1c13944a0899ed4a25f17eed2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Neoplasm Recurrence, Local
114 rdf:type schema:DefinedTerm
115 N50b1a1c105d740298d510c6039f4fefe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Retrospective Studies
117 rdf:type schema:DefinedTerm
118 N532f4251a4d9498b88ff9e73313aecba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Aged
120 rdf:type schema:DefinedTerm
121 N5404fb0d6f50414fb6df6c9311a67f1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Methotrexate
123 rdf:type schema:DefinedTerm
124 N56a74da7d4654d26886d09ccee703cc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 N5d9435e70afd4af693f3cb2af58e3b2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Lymphoma
129 rdf:type schema:DefinedTerm
130 N7859aa86e33c4e7eb1781843fd943f68 schema:name readcube_id
131 schema:value df1a59daf0b531b817e65b5169a7b1d6334c4d488614c6794052ced6143edc4b
132 rdf:type schema:PropertyValue
133 N806608e5bf2a474bba2cacbb77b6d9b9 schema:volumeNumber 118
134 rdf:type schema:PublicationVolume
135 N8f1b8846d3ae482ba601583cd79f0fca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Follow-Up Studies
137 rdf:type schema:DefinedTerm
138 N9af8070b0f7d40ac84065dde8e9400e1 schema:name nlm_unique_id
139 schema:value 8309335
140 rdf:type schema:PropertyValue
141 N9d812594681f442db7528c4527334bb8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Nitrogen Mustard Compounds
143 rdf:type schema:DefinedTerm
144 Na0deb6ea4ebd492a9446d794947f1f0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Humans
146 rdf:type schema:DefinedTerm
147 Nba9ce44920d543f09fbf1c5a3a64d224 schema:issueNumber 1
148 rdf:type schema:PublicationIssue
149 Nc878683238fa46e5bc3d5034bdfb391f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Bendamustine Hydrochloride
151 rdf:type schema:DefinedTerm
152 Ne23cf0278ace4c49a9abdeb0a5ba32d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Antineoplastic Agents, Alkylating
154 rdf:type schema:DefinedTerm
155 Ne800ee8bbdc94840b15f478e098fd71c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Disease-Free Survival
157 rdf:type schema:DefinedTerm
158 Nef3e9b242ca640f3aeebaa7fe4413bc1 schema:name dimensions_id
159 schema:value pub.1046834783
160 rdf:type schema:PropertyValue
161 Nf7594704a6e948d594bc15fb719bb79d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Treatment Outcome
163 rdf:type schema:DefinedTerm
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
168 schema:name Oncology and Carcinogenesis
169 rdf:type schema:DefinedTerm
170 sg:journal.1094205 schema:issn 0167-594X
171 1573-7373
172 schema:name Journal of Neuro-Oncology
173 rdf:type schema:Periodical
174 sg:person.01326261166.36 schema:affiliation N4220b68a13734342a5ec63e587e46b9a
175 schema:familyName Chamberlain
176 schema:givenName Marc C.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
178 rdf:type schema:Person
179 sg:pub.10.1007/s11060-007-9464-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007719563
180 https://doi.org/10.1007/s11060-007-9464-6
181 rdf:type schema:CreativeWork
182 sg:pub.10.1007/s11060-010-0497-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053593627
183 https://doi.org/10.1007/s11060-010-0497-x
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/s11060-011-0612-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050266838
186 https://doi.org/10.1007/s11060-011-0612-7
187 rdf:type schema:CreativeWork
188 sg:pub.10.1007/s11060-013-1085-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002877031
189 https://doi.org/10.1007/s11060-013-1085-7
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/s11060-013-1196-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035812481
192 https://doi.org/10.1007/s11060-013-1196-1
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/s11912-012-0251-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1041742002
195 https://doi.org/10.1007/s11912-012-0251-y
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/sj.bjc.6603660 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003449325
198 https://doi.org/10.1038/sj.bjc.6603660
199 rdf:type schema:CreativeWork
200 sg:pub.10.1038/sj.bmt.1705452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045484144
201 https://doi.org/10.1038/sj.bmt.1705452
202 rdf:type schema:CreativeWork
203 sg:pub.10.2165/11209510-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000180988
204 https://doi.org/10.2165/11209510-000000000-00000
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1002/(sici)1097-0142(20000201)88:3<637::aid-cncr22>3.0.co;2-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1003043958
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1002/cncr.20339 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026362836
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1002/cncr.26709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012698413
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/s0140-6736(09)61416-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031922698
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/s1470-2045(10)70229-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034898942
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1034/j.1600-0609.2003.00045.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004310095
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/annonc/mdl070 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041563711
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/annonc/mdl458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000595164
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1093/jnci/80.17.1408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059814834
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1093/neuonc/noq011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000678444
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1158/1078-0432.ccr-04-0159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021593241
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1200/jco.2001.19.3.742 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074750681
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1200/jco.2002.11.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203163
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1200/jco.2003.03.036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203440
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1200/jco.2005.01.161 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017320169
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.2005.04.8819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204236
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.2005.13.524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003658256
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1200/jco.2006.06.2117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050156129
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2008.18.7252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000657227
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1200/jco.2012.46.9957 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041546845
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1212/01.wnl.0000137050.43114.42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346302
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1212/01.wnl.0000276986.19602.c1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064349586
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1212/wnl.0b013e31820f2d94 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064355987
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1212/wnl.54.8.1707 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064378617
253 rdf:type schema:CreativeWork
254 https://doi.org/10.3324/haematol.11771 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013678538
255 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...